IE
RANI icon

Israel Englander’s Rani Therapeutics RANI Stock Holding History

Israel Englander’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-405,669
Closed -$298K – 6314
2026
Q1 		$298K Buy
405,669
+242,369
+148% +$310K ﹤0.01% 5011
2025
Q4 		$220K Buy
+163,300
New +$246K ﹤0.01% 5425
2024
Q4 		– Sell
-11,447
Closed -$24.7K – 6377
2024
Q3 		$24.7K Buy
+11,447
New +$32.8K ﹤0.01% 5778
2023
Q4 		– Sell
-46,137
Closed -$100K – 6453
2023
Q3 		$100K Sell
46,137
-87,324
-65% -$334K ﹤0.01% 5337
2023
Q2 		$550K Buy
133,461
+58,893
+79% +$273K ﹤0.01% 4475
2023
Q1 		$385K Buy
74,568
+1,424
+2% +$8.56K ﹤0.01% 4751
2022
Q4 		$432K Sell
73,144
-15,990
-18% -$117K ﹤0.01% 4845
2022
Q3 		$854K Sell
89,134
-22,647
-20% -$240K ﹤0.01% 4473
2022
Q2 		$1.16M Buy
111,781
+79,256
+244% +$910K ﹤0.01% 4236
2022
Q1 		$439K Buy
+32,525
New +$540K ﹤0.01% 5227
2021
Q4 		– Sell
-28,996
Closed -$517K – 7277
2021
Q3 		$517K Buy
+28,996
New +$502K ﹤0.01% 5317

Other funds holding RANI

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LP
Longaeva Partners Chicago, Illinois $4.58B AUM 43.91% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Israel Englander's RANI Position: Q2 2026 in Review

Israel Englander sold out of Rani Therapeutics (RANI) in Q2 2026, closing a stake of 405,669 shares — an estimated $298K sold.

Israel Englander first reported a position in RANI in Q3 2021 and held it in 11 quarters. The position peaked at $1.16M in Q2 2022. 67 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

  • Israel Englander reported no remaining Rani Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 405,669 Rani Therapeutics shares in Q2 2026, an estimated $298K.
  • Israel Englander first reported a position in Rani Therapeutics in Q3 2021 and held it in 11 quarters.
  • Israel Englander's Rani Therapeutics position peaked at $1.16M in Q2 2022.
  • 67 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.